[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:dna-mismatch-repair-protein-mlh1":3},{"name":4,"total":5,"recruiting":6,"trials":7},"DNA Mismatch Repair Protein Mlh1",24,17,[8,16,23,30,37,43,49,55,61,67,73,79,85,91,97,103,109,115,122,128,134,140,146,153],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06844383","A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate",[12],"Phase 2","RECRUITING","2026-08-26T02:17:43.321968Z","2026-05-05T02:43:29.708217Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05013216","Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer",[20],"Phase 1","2026-08-26T02:16:23.080181Z","2026-05-05T02:43:26.738998Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06122896","Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals",[27],"Early Phase 1","2026-08-26T02:17:13.277148Z","2026-05-05T02:43:27.075591Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":35,"content_modified":36},"NCT02000089","The Cancer of the Pancreas Screening-5 CAPS5)Study",[34],"Phase 3","2026-08-26T02:17:20.511551Z","2026-05-05T02:43:27.641158Z",{"nct_id":38,"title":39,"phases":40,"status":13,"updated_at":41,"content_modified":42},"NCT07612046","A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening",[],"2026-08-26T02:16:27.227548Z","2026-07-19T19:36:05.076756Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":47,"content_modified":48},"NCT07645391","Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer",[],"2026-08-26T02:16:05.813655Z","2026-06-14T18:39:22.265063Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT06898996","FITting Non-invasive Tests in Lynch Syndrome Surveillance",[],"2026-08-26T02:16:00.194860Z","2026-05-13T02:55:06.589406Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT06582914","Lynch Syndrome Integrative Epidemiology and Genetics",[],"2026-08-26T02:19:04.543908Z","2026-05-13T02:55:06.551040Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06271291","Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts",[],"2026-08-26T02:18:36.226508Z","2026-05-13T02:55:06.430707Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT05410977","Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients",[],"2026-08-26T02:18:17.950264Z","2026-05-13T02:55:06.347175Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT05129605","Prostate Cancer Genetic Risk Evaluation and Screening Study",[],"2026-08-26T02:18:25.327036Z","2026-05-13T02:55:06.292506Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT05006131","Pancreatic Cancer Screening for At-risk Individuals",[],"2026-08-26T02:17:12.307088Z","2026-05-13T02:55:06.277680Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT04706663","Precision-Based Genomics in Prostate Cancer",[],"2026-08-26T02:17:23.750999Z","2026-05-13T02:55:06.268346Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT03805919","Men at High Genetic Risk for Prostate Cancer",[],"2026-08-26T02:15:18.897219Z","2026-05-13T02:55:06.177945Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT03250078","A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.120432Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT06708429","Lynch Syndrome X-Talk of Enteral Mucosa With Immune System",[],"2026-08-26T02:15:03.757872Z","2026-05-13T02:55:06.566940Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT04970056","Pancreatic Cancer Early Detection Consortium",[],"2026-08-26T02:15:04.877798Z","2026-05-13T02:55:06.276618Z",{"nct_id":116,"title":117,"phases":118,"status":119,"updated_at":120,"content_modified":121},"NCT07729046","Neu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+\u002FHER2- Breast Cancer",[12],"NOT_YET_RECRUITING","2026-08-26T02:15:38.131683Z","2026-07-30T01:46:14.449733Z",{"nct_id":123,"title":124,"phases":125,"status":119,"updated_at":126,"content_modified":127},"NCT07723651","[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)",[12],"2026-08-26T02:19:11.399072Z","2026-07-24T01:27:14.924205Z",{"nct_id":129,"title":130,"phases":131,"status":119,"updated_at":132,"content_modified":133},"NCT07318363","IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention",[34],"2026-08-26T02:19:16.454910Z","2026-07-19T19:36:05.074594Z",{"nct_id":135,"title":136,"phases":137,"status":119,"updated_at":138,"content_modified":139},"NCT07565467","ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)",[],"2026-08-26T02:17:59.904383Z","2026-05-13T02:55:06.729283Z",{"nct_id":141,"title":142,"phases":143,"status":119,"updated_at":144,"content_modified":145},"NCT07542405","A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families",[],"2026-08-26T02:17:44.240289Z","2026-05-05T02:43:27.431566Z",{"nct_id":147,"title":148,"phases":149,"status":150,"updated_at":151,"content_modified":152},"NCT07358208","Prospective Familial Registry for Pancreas Research",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:26.493949Z","2026-06-16T05:54:07.881076Z",{"nct_id":154,"title":155,"phases":156,"status":150,"updated_at":157,"content_modified":158},"NCT06914726","Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes",[],"2026-08-26T02:18:57.189473Z","2026-06-16T05:54:07.839283Z"]